跳至主要内容
临床试验/NCT05370066
NCT05370066Unknown不适用

Anonymized Data Collection From the CS6BP and Other Modalities for the Purpose of Developing Continuous, Absolute, Non-Inflating Measurement of Blood Pressure

CardiacSense Ltd.2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年12月17日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
2
主要终点
Performance of CS6BP

研究概览

简要总结

This study is performed on hospitalized subjects in the Internal Medicine Division. The study is intended for data collection. The data will be obtained from commercially available blood pressure monitors and simultaneously from the CS6BP watch.

详细描述

This is a prospective open-label study. Hospitalized subjects from Internal Medicine Division will be measured simultaneously with a commercially available blood pressure monitor and CS6BP watch. Subjects may be measured at the clinic or home up to one month following their discharge from the hospital.

Screening:

PI or delegated physician will confirm the eligibility of subjects. Eligible subjects will sign an informed consent form before any study procedure initiation.

Recording session during hospitalization:

Each subject will undergo up to 15 blood pressure measurement sessions during the hospitalization period. The subject will be connected to the CS6BP device and a cuff simultaneously during the session. There will be at least 30 minutes intervals between the end of the session to the beginning of the next session.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

盲法说明

open label study

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age of eighteen (18) year and above
  • Ability and willingness to sign an informed consent form

排除标准

  • Subjects with hemodynamic support
  • Subjects receiving more than 2-3 l of fluid per 24h
  • Subjects with septic shock
  • Subjects with distal edema
  • Subjects with arms trauma, where the watch is not wearable
  • Subjects where the radial artery could not be palpate
  • Subjects with life expectancy of less than 24h
  • Subjects who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the subject's participation in this study
  • Any concomitant condition which, in the opinion of the investigator, would not allow safe participation in the study (e.g. drug addiction, alcohol abuse, emotional/psychological diagnosis)

结局指标

主要结局

Performance of CS6BP

时间窗: up to 1 month

Assessment of the performance sensitivity of CS6BP in measuring blood pressure

Safety Any adverse event observed during the study will be recorded during the study.

时间窗: through study completion, an average of 18 months

Assessment of the safety of using CS6BP for blood pressure measurement

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验